Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Journal of the Neurological Sciences
|
January 27, 2016
Ingested (oral) anti-IL-12/23 inhibits EAE
Staley A Brod
Experimental Biology and Medicine (Maywood, N.J.)
|
December 18, 2002
Ingested type I interferon: state of the art as treatment for autoimmunity
Staley A Brod
Autoimmunity Reviews
|
August 13, 2022
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica
Staley A Brod
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 13, 2003
Ingested type I interferon: a potential treatment for autoimmunity
Staley A Brod
Multiple Sclerosis and Related Disorders
|
October 15, 2020
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Staley A Brod
Autoimmunity Reviews
|
August 20, 2021
A proposal: How to study pro-myelinating proteins in MS
Staley A Brod
Journal of Alzheimer'S Disease : JAD
|
November 29, 2021
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease
Staley A Brod
Cytokine
|
July 4, 2016
Ingested (oral) rituximab inhibits EAE
Staley A Brod
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2
Staley A Brod
Multiple Sclerosis and Related Disorders
|
February 3, 2020
In MS: Immunosuppression is passé
Staley A Brod
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Journal of the Neurological Sciences
|
January 27, 2016
Ingested (oral) anti-IL-12/23 inhibits EAE
Staley A Brod
Experimental Biology and Medicine (Maywood, N.J.)
|
December 18, 2002
Ingested type I interferon: state of the art as treatment for autoimmunity
Staley A Brod
Autoimmunity Reviews
|
August 13, 2022
The genealogy, methodology, similarities and differences of immune reconstitution therapies for multiple sclerosis and neuromyelitis optica
Staley A Brod
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
February 13, 2003
Ingested type I interferon: a potential treatment for autoimmunity
Staley A Brod
Multiple Sclerosis and Related Disorders
|
October 15, 2020
Review of approved NMO therapies based on mechanism of action, efficacy and long-term effects
Staley A Brod
Autoimmunity Reviews
|
August 20, 2021
A proposal: How to study pro-myelinating proteins in MS
Staley A Brod
Journal of Alzheimer'S Disease : JAD
|
November 29, 2021
Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease
Staley A Brod
Cytokine
|
July 4, 2016
Ingested (oral) rituximab inhibits EAE
Staley A Brod
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Ingested Type I Interferon-State of the Art as Treatment for Autoimmunity Part 2
Staley A Brod
Multiple Sclerosis and Related Disorders
|
February 3, 2020
In MS: Immunosuppression is passé
Staley A Brod
Page
of 3